NEW YORK (GenomeWeb News) – NuGen Technologies will collaborate with Roche Applied Sciences to research and develop a NimbleGen array application for use with small, degraded, and compromised samples that can be used in gene expression analysis studies, the firms said today.
The microarray application, designed for use with NuGen’s WT-Ovation technology, will allow scientists to amplify picograms of RNA into micrograms of cDNA that can be used for gene expression analysis, sample sharing, and archiving, the company said.
Gerd Maass, head of Roche NimbleGen, said in a statement that the goal “is to give researchers access to a broader range of small and precious samples than they’ve been previously able to investigate.” Maass explained that such access would enable scientists to “unlock information in complex sample types including LCM or tissue biopsies that yield extremely small amounts of compromised RNA.”
“Use of smaller samples minimizes the averaging that takes place, enabling researchers to discover details of the tissue or cells of interest,” NuGen VP of R&D Doug Amorese added in the joint statement.
Financial terms of the agreement and commercialization plans were not released.